18β-glycyrrhetinic acid suppresses experimental autoimmune encephalomyelitis through inhibition of microglia activation and promotion of remyelination

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Zhou, Jieru ^a,b   Cai, Wei ^c   Jin, Min ^b,c   Xu, Jingwei ^c   Wang, Yanan ^c   Xiao, Yichuan ^c   Hao, Li ^d   Wang, Bei ^c   Zhang, Yanyun ^c   Han, Jie ^a   Huang, Rui ^b  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

18ALPHA-GLYCYRRHETINIC ACID; BRAIN DERIVED NEUROTROPHIC FACTOR; CHEMOKINE; GLYCYRRHETINIC ACID;

ANALOGS AND DERIVATIVES; ANIMAL; ASTROCYTE; C57BL MOUSE; CENTRAL NERVOUS SYSTEM; DRUG EFFECTS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; INFLAMMATION; METABOLISM; MICROGLIA; MYELIN SHEATH; PATHOLOGY; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; ASTROCYTES; BRAIN-DERIVED NEUROTROPHIC FACTOR; CENTRAL NERVOUS SYSTEM; CHEMOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GLYCYRRHETINIC ACID; INFLAMMATION; MAP KINASE SIGNALING SYSTEM; MICE, INBRED C57BL; MICROGLIA; MYELIN SHEATH; T-LYMPHOCYTES;

EID: 84940886858     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep13713     Document Type: Article

References (41)

1. Nelson, P. T., Soma, L. A. & Lavi, E. Microglia in diseases of the central nervous system. Ann Med 34, 491-500 (2002).
2. Nimmerjahn, A., Kirchhoff, F. & Helmchen, F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308, 1314-8 (2005).
3. Gonzalez-Scarano, F. & Baltuch, G. Microglia as mediators of inflammatory and degenerative diseases. Annu Rev Neurosci 22, 219-40 (1999).
4. Yang, G., Parkhurst, C. N., Hayes, S. & Gan, W. B. Peripheral elevation of TNF-Alpha leads to early synaptic abnormalities in the mouse somatosensory cortex in experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 110, 10306-11 (2013).
5. Heppner, F. L. et al. Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat Med 11, 146-52 (2005).
6. Kreutzberg, G. W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 19, 312-8 (1996).
7. Sorensen, T. L. et al. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest 103, 807-15 (1999).
8. Butovsky, O. et al. Induction and blockage of oligodendrogenesis by differently activated microglia in an animal model of multiple sclerosis. J Clin Invest 116, 905-15 (2006).
9. Emmetsberger, J. & Tsirka, S. E. Microglial inhibitory factor (MIF/TKP) mitigates secondary damage following spinal cord injury. Neurobiol Dis 47, 295-309 (2012).
10. Linker, R. A. et al. Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis. Brain 133, 2248-63 (2010).
11. Xiao, Y. et al. Genetic ablation of steroid receptor coactivator-3 promotes PPAR-beta-mediated alternative activation of microglia in experimental autoimmune encephalomyelitis. Glia 58, 932-42 (2010).
12. Xiao, Y. et al. 18Beta-glycyrrhetinic acid ameliorates acute Propionibacterium acnes-induced liver injury through inhibition of macrophage inflammatory protein-1alpha. J Biol Chem 285, 1128-37 (2010).
13. Kao, T. C., Shyu, M. H. & Yen, G. C. Neuroprotective effects of glycyrrhizic acid and 18beta-glycyrrhetinic acid in PC12 cells via modulation of the PI3K/Akt pathway. J Agric Food Chem 57, 754-61 (2009).
14. Codarri, L. et al. RORgammat drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat Immunol 12, 560-7 (2011).
15. El-Behi, M. et al. The encephalitogenicity of T(H)17 cells is dependent on IL-1-And IL-23-induced production of the cytokine GM-CSF. Nat Immunol 12, 568-75 (2011).
16. Piqueras, L. et al. Activation of PPARbeta/delta inhibits leukocyte recruitment, cell adhesion molecule expression, and chemokine release. J Leukoc Biol 86, 115-22 (2009).
17. Gerard, C. & Rollins, B. J. Chemokines and disease. Nat Immunol 2, 108-15 (2001).
18. Ambrosini, E. & Aloisi, F. Chemokines and glial cells: a complex network in the central nervous system. Neurochem Res 29, 1017-38 (2004).
19. Carson, M. J. Microglia as liaisons between the immune and central nervous systems: functional implications for multiple sclerosis. Glia 40, 218-31 (2002).
20. Ponomarev, E. D., Shriver, L. P., Maresz, K. & Dittel, B. N. Microglial cell activation and proliferation precedes the onset of CNS autoimmunity. J Neurosci Res 81, 374-89 (2005).
21. Piao, Z. G. et al. Activation of glia and microglial p38 MAPK in medullary dorsal horn contributes to tactile hypersensitivity following trigeminal sensory nerve injury. Pain 121, 219-31 (2006).
22. Zhou, Y., Ling, E. A. & Dheen, S. T. Dexamethasone suppresses monocyte chemoattractant protein-1 production via mitogen activated protein kinase phosphatase-1 dependent inhibition of Jun N-terminal kinase and p38 mitogen-Activated protein kinase in activated rat microglia. J Neurochem 102, 667-78 (2007).
23. Franklin, R. J. & Ffrench-Constant, C. Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci 9, 839-55 (2008).
24. Duncan, I. D., Brower, A., Kondo, Y., Curlee, J. F., Jr. & Schultz, R. D. Extensive remyelination of the CNS leads to functional recovery. Proc Natl Acad Sci USA 106, 6832-6 (2009).
25. Liu, L. et al. Myelin repair is accelerated by inactivating CXCR2 on nonhematopoietic cells. J Neurosci 30, 9074-83 (2010).
26. Jurevics, H. et al. Alterations in metabolism and gene expression in brain regions during cuprizone-induced demyelination and remyelination. J Neurochem 82, 126-36 (2002).
27. Mi, S. et al. LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis. Nat Med 13, 1228-33 (2007).
28. Zhang, Y. et al. Notch1 signaling plays a role in regulating precursor differentiation during CNS remyelination. Proc Natl Acad Sci USA 106, 19162-7 (2009).
29. Girard, C. et al. Grafts of brain-derived neurotrophic factor and neurotrophin 3-transduced primate Schwann cells lead to functional recovery of the demyelinated mouse spinal cord. J Neurosci 25, 7924-33 (2005).
30. Vondran, M. W., Clinton-Luke, P., Honeywell, J. Z. & Dreyfus, C. F. BDNF+/? mice exhibit deficits in oligodendrocyte lineage cells of the basal forebrain. Glia 58, 848-56 (2010).
31. Becher, B., Prat, A. & Antel, J. P. Brain-immune connection: immuno-regulatory properties of CNS-resident cells. Glia 29, 293-304 (2000).
32. Babcock, A. A., Kuziel, W. A., Rivest, S. & Owens, T. Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. J Neurosci 23, 7922-30 (2003).
33. Guan, X., Wilson, S., Schlender, K. K. & Ruch, R. J. Gap-junction disassembly and connexin 43 dephosphorylation induced by 18 beta-glycyrrhetinic acid. Mol Carcinog 16, 157-64 (1996).
34. Yamamoto, Y., Fukuta, H., Nakahira, Y. & Suzuki, H. Blockade by 18beta-glycyrrhetinic acid of intercellular electrical coupling in guinea-pig arterioles. J Physiol 511 (Pt 2), 501-8 (1998).
35. Gupta, P., Das, P. K. & Ukil, A. Antileishmanial Effect of 18beta-Glycyrrhetinic Acid Is Mediated by Toll-Like Receptor-Dependent Canonical and Noncanonical p38 Activation. Antimicrob Agents Chemother 59, 2531-9 (2015).
36. Jeong, H. G. et al. Hepatoprotective effects of 18beta-glycyrrhetinic acid on carbon tetrachloride-induced liver injury: inhibition of cytochrome P450 2E1 expression. Pharmacol Res 46, 221-7 (2002).
37. Eugenin, E. A. et al. The role of gap junction channels during physiologic and pathologic conditions of the human central nervous system. J Neuroimmune Pharmacol 7, 499-518 (2012).
38. Aharoni, R., Arnon, R. & Eilam, R. Neurogenesis and neuroprotection induced by peripheral immunomodulatory treatment of experimental autoimmune encephalomyelitis. J Neurosci 25, 8217-28 (2005).
39. Du, Y., Fischer, T. Z., Lee, L. N., Lercher, L. D. & Dreyfus, C. F. Regionally specific effects of BDNF on oligodendrocytes. Dev Neurosci 25, 116-26 (2003).
40. Du, Y., Fischer, T. Z., Clinton-Luke, P., Lercher, L. D. & Dreyfus, C. F. Distinct effects of p75 in mediating actions of neurotrophins on basal forebrain oligodendrocytes. Mol Cell Neurosci 31, 366-75 (2006).
41. Stromnes, I. M. & Goverman, J. M. Passive induction of experimental allergic encephalomyelitis. Nat Protoc 1, 1952-60 (2006).